AMERICAN SHARED HOSPITAL SERVICES Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $7.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-31
- AMERICAN SHARED HOSPITAL SERVICES effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $7.00K, a 46.15% decline from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $13.00K, a 87.74% decline from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $106.00K, a 36.90% decline from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $168.00K, a 309.76% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2025-12-31 | $7.00K 10-K · filed 2026-03-31 |
| 2024-12-31 | $13.00K 10-K · filed 2025-04-04 |
| 2023-12-31 | $106.00K 10-K · filed 2025-04-04 |
| 2022-12-31 | $168.00K 10-K · filed 2024-04-01 |
| 2021-12-31 | $41.00K 10-K · filed 2023-03-31 |
| 2020-12-31 | $259.00K 10-K · filed 2022-03-30 |
| 2019-12-31 | $0.00 10-K · filed 2020-04-03 |
| 2018-12-31 | $0.00 10-K · filed 2020-04-03 |
| 2017-12-31 | -$1.55M 10-K · filed 2020-04-03 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-29 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |